Clinical Trial

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

Name: GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer — clinical trial record (NCT07489287)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This phase 1 study evaluates the safety, efficacy, and biological activity of GB-5267 in patients with platinum-resistant ovarian cancer.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-09

Trial Details

NCT Number	NCT07489287
Lead Sponsor	Roswell Park Cancer Institute Collaborators: Generate Biomedicines
Conditions	Platinum-resistant Ovarian Cancer
Enrollment	18 participants
Start Date	2026-07-15
Primary Completion	2028-01-15 (estimated)
Study Completion	2030-01-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-22